Finally, in patients affected by myeloproliferative disorders (MPD), such as chronic myelomonocytic leukemia or primary myelofibrosis, oncogenic RET fusions with BCR or FGFR1OP genes were identified [9, 10]. This evidence concerns the gene CEP43 and myeloproliferative disorder.